Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07322094 · ClinicalTrials.gov registry record · Phase 1

CATALINA-4: A Study to Investigate the Safety and Efficacy of TORL-1-23 With Chemotherapy Given Before Initial Surgery in Women With Advanced Stage Ovarian Cancer

A Phase 1 study of Primary Peritoneal Cancer and Fallopian Tube Cancers, sponsored by TORL Biotherapeutics.

Recruiting
Registry status
Phase 1
Development phase
60
Enrollment target
1
Study location

NCT07322094 is a Phase 1 study of Primary Peritoneal Cancer and Fallopian Tube Cancers that is actively recruiting participants, run by TORL Biotherapeutics. The registered enrollment target is 60 participants, below the 150-participant average among 27 other Primary Peritoneal Cancer trials with a reported enrollment target (60% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07322094, a Phase 1 study of Primary Peritoneal Cancer and Fallopian Tube Cancers, is actively recruiting participants, sponsored by TORL Biotherapeutics.

RECRUITING
Registry status
Phase 1
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

A Phase 1B/2 Study to Investigate the Safety and Efficacy of TORL-1-23 with Chemotherapy Given Before Initial Surgery in Women with Advanced Stage Ovarian Cancer

Conditions Studied

Primary Peritoneal Cancer Fallopian Tube Cancers FIGO Stage III and IV Ovarian Cancer

Interventions

  • COMBINATION_PRODUCT TORL-1-23 and paclitaxel
  • COMBINATION_PRODUCT TORL-1-23 and carboplatin
  • COMBINATION_PRODUCT TORL-1-23, paclitaxel, and carboplatin

Study Locations (1)

California

  • UCLA - Los Angeles

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2025-12-10
Est. Completion 2028-01
Phase Phase 1

Sponsor

TORL Biotherapeutics

8 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT07322094

The ClinicalTrials.gov registry entry for NCT07322094 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 150-participant average among 27 other Primary Peritoneal Cancer trials with a reported enrollment target (60% lower). The listed sponsor is TORL Biotherapeutics, which has 8 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Primary Peritoneal Cancer appearing as the primary indexed condition, and to 3 interventions - of which TORL-1-23 and paclitaxel is the first listed.

NCT07322094 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT07322094 about?

NCT07322094 is a clinical study titled "CATALINA-4: A Study to Investigate the Safety and Efficacy of TORL-1-23 With Chemotherapy Given Before Initial Surgery in Women With Advanced Stage Ovarian Cancer". A Phase 1B/2 Study to Investigate the Safety and Efficacy of TORL-1-23 with Chemotherapy Given Before Initial Surgery in Women with Advanced Stage Ovarian Cancer

What is the current status of trial NCT07322094?

This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 60 participants. The study started on 2025-12-10. Estimated completion is 2028-01.

What conditions does trial NCT07322094 study?

This clinical trial studies the following conditions: Primary Peritoneal Cancer, Fallopian Tube Cancers, FIGO Stage III and IV Ovarian Cancer.

What interventions are being tested in trial NCT07322094?

The interventions under investigation include: TORL-1-23 and paclitaxel (COMBINATION_PRODUCT), TORL-1-23 and carboplatin (COMBINATION_PRODUCT), TORL-1-23, paclitaxel, and carboplatin (COMBINATION_PRODUCT).

Who is sponsoring clinical trial NCT07322094?

This trial is sponsored by TORL Biotherapeutics, which has 8 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07322094 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Primary Peritoneal Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Primary Peritoneal Cancer

All registered trials for this condition

Fallopian Tube Cancers

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.